Kora Saúde Participações S.A.

B3:KRSA3.SA

8.87 (BRL) • At close April 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 556.447564.066582.574565.143564.689576.951565.02553.027537.978511.222518.786478.743414.048324.464306.762216.582444.616154.868136.022139.803
Cost of Revenue 443.068461.284466.732442.868450.323479.349438.288428.987430.554402.849375.066350.315334.767237.273214.421152.693267.559120.632101.686104.851
Gross Profit 113.379102.782115.842122.275114.36697.602126.732124.04107.424108.373143.72128.42879.28187.19192.34163.889177.05734.23634.33634.952
Gross Profit Ratio 0.2040.1820.1990.2160.2030.1690.2240.2240.20.2120.2770.2680.1910.2690.3010.2950.3980.2210.2520.25
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 22.4847.83145.41910.95112.17614.15115.26620.36922.22117.94116.2294.9678.9529.84712.5588.713120.4136.60316.11520.472
Selling & Marketing Expenses 00023.11516.41711.4045.57500012.89200000000
SG&A 22.4847.83145.41934.06628.59325.55115.26665.94422.22117.94116.22917.8598.9529.84712.5588.713120.4136.60316.11520.472
Other Expenses 34.03335.2960.1141.5790.3610.15334.8535.641-0.4690038.42183.21331.39200-27.143-3.51200
Operating Expenses 58.23642.22345.53344.41528.23225.39849.35471.58530.35361.48256.23856.2883.97740.88928.0324.20293.273.09116.11520.472
Operating Income 56.86259.65570.30976.09674.16672.22976.61352.45557.33950.92287.48272.148-19.08935.70659.21839.68783.78731.14517.85514.185
Operating Income Ratio 0.1020.1060.1210.1350.1310.1250.1360.0950.1070.10.1690.151-0.0460.110.1930.1830.1880.2010.1310.101
Total Other Income Expenses Net -155.264-91.224-95.722-94.628-102.917-100.463-108.314-97.755-124.424-104.32-76.099-52.767-39.548-32.065-26.583-14.492-78.8-8.31-8.875-12.129
Income Before Tax -98.402-31.569-25.413-18.532-28.751-28.234-31.701-45.3-67.085-53.39811.38319.381-58.6373.64132.63525.1954.98722.8358.982.056
Income Before Tax Ratio -0.177-0.056-0.044-0.033-0.051-0.049-0.056-0.082-0.125-0.1040.0220.04-0.1420.0110.1060.1160.0110.1470.0660.015
Income Tax Expense 7.324-20.070.6786.607-9.19413.54916.9942.735-8.0632.07610.4490.28716.21318.35812.13211.0862.9569.6722.3791.077
Net Income -104.727-25.977-27.943-27.864-18.935-45.269-52.542-50.878-63.52-55.435-2.78714.154-78.396-16.29918.33612.6414.18910.3685.3940.655
Net Income Ratio -0.188-0.046-0.048-0.049-0.034-0.078-0.093-0.092-0.118-0.108-0.0050.03-0.189-0.050.060.0580.0090.0670.040.005
EPS -1.15-0.34-0.34-0.36-0.025-0.58-0.68-0.66-0.082-0.72-0.0370.19-0.1-0.30.240.17-00.140.370.005
EPS Diluted -1.15-0.34-0.34-0.36-0.025-0.58-0.68-0.66-0.08-0.72-0.0370.18-0.1-0.30.240.17-00.140.370.005
EBITDA 60.30497.03795.726102.985112.945106.9995.62886.639108.66891.76295.43993.93411.16255.62770.10647.40298.87236.10422.40620.515
EBITDA Ratio 0.1080.1720.1640.1820.20.1850.1690.1570.2020.1790.1840.1960.0270.1710.2290.2190.2220.2330.1650.147